A new Lancet Commission reports shows for the first time that the main killers of the poorest billion people in the world aren’t traditional “diseases of poverty” such as tuberculosis or neglected tropical diseases, but are non-communicable disease such as heart diseases and stroke, and injuries. The Lancet NCDs and Injuries (NCDI) Poverty Commission found that these […] Continue reading ->
The United Nations General Assembly adopted an omnibus resolution urging Member States to mount a coordinated global coronavirus response on 11 September. The resolution (Document A/74/L.92), submitted by the President of the Assembly Tijjani Muhammad-Bande, was almost passed unanimously, with only two countries voting against and two abstaining. United States & Israel Vote Against the […] Continue reading ->
AstraZeneca resumed clinical trials for its investigational COVID-19 vaccine Saturday, after briefly pausing the trial globally to investigate reports of a potential severe adverse in a patient in the United Kingdom. In a brief press release, AstraZeneca announced that Phase 3 trials for the vaccine, AZD1222, have resumed in the UK on 12 September following […] Continue reading ->
COVID-19 has the potential to change how vaccines are sold and distributed, but industry leaders, academics, policymakers, and advocates are still struggling to decide the direction those changes should take. A successful COVID-19 vaccine should only be sold by companies to countries if it fits within an equitable distribution platform made by a neutral third […] Continue reading ->
AstraZeneca on Tuesday night suspended the Phase 3 trial of their experimental COVID-19 vaccine in order to investigate a a suspected severe adverse reaction in a volunteer reported in the United Kingdom. The trial suspension follows just on the heels of AstraZeneca’s chief executive officer’s pledge to seek regulatory approval for a COVID-19 vaccine only […] Continue reading ->
The chief executive officers of nine biopharmaceutical companies at the forefront of the COVID-19 vaccine development race have signed a pledge to fully test the safety and efficacy of an investigational vaccine before rolling it out for mass use. The top executives of AstraZeneca, BioNTech, GlaxoKlineSmith, Johnson&Johnson, Merck, Moderna, Novavax, Sanofi, and Pfizer signed the […] Continue reading ->
Countries would be better off waiting until Phase 3 clinical trials, which test the safety and efficacy of an experimental vaccine in tens of thousands of people, are completed before rolling out the vaccine for wider use, World Health Organization Chief Scientist Soumya Swaminathan said on Monday. Although some countries, including China, Russia and the […] Continue reading ->
The US Biomedical Advanced Research and Development Agency (BARDA) is investigating Moderna’s patents for allegedly failing to disclose federal funding, making it the second US agency to review the company’s patents. The BARDA probe comes just days after the US Defense Advanced Research Projects Agency (DARPA) began an investigation into Moderna’s patents, after pharma watchdog […] Continue reading ->